In vitro Activity of Ceftolozane/Tazobactam Alone or with an Aminoglycoside Against Multi-Drug-Resistant Pseudomonas aeruginosa from Pediatric Cystic Fibrosis Patients.

Dassner, Aimee M; Sutherland, Christina; Girotto, Jennifer; Nicolau, David P

Dassner, Aimee M; Sutherland, Christina; Girotto, Jennifer; Nicolau, David P.

Afiliación

Dassner AM; Connecticut Children's Medical Center, Hartford, CT, USA.
Sutherland C; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.
Girotto J; Connecticut Children's Medical Center, Hartford, CT, USA.
Nicolau DP; University of Connecticut School of Pharmacy, Storrs, CT, USA.

Infect Dis Ther ; 6(1): 129-136, 2017 Mar.

Article en En | MEDLINE | ID: mdl-27943223

Palabras clave

Combination therapy; Cystic fibrosis; Pediatric; Pseudomonas; Time-kill

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_medicamentos_vacinas_tecnologias Tipo de estudio: Prognostic_studies Idioma: En Revista: Infect Dis Ther Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google